ASPN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Aspen Aerogels Inc (ASPN) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is significantly deteriorating, insider selling is increasing, and analysts have lowered price targets while expressing concerns about near-term challenges. Additionally, there are no positive trading signals or recent news catalysts to support a bullish case.
The technical indicators show a bearish trend. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key pivot levels. While the MACD is slightly positive, the RSI is neutral, providing no clear bullish signal.
NULL identified. No recent news or significant positive developments.
Analysts have lowered price targets significantly, citing challenges with GM's electric vehicle outlook and macroeconomic headwinds.
Insiders are selling heavily, with a 288.04% increase in selling activity over the last month.
The company's financial performance has deteriorated sharply, with revenue, net income, EPS, and gross margin all showing significant YoY declines.
In Q4 2025, the company's revenue dropped by -66.42% YoY to $41.34M. Net income fell by -741.73% YoY to -$72.91M, and EPS declined by -728.57% YoY to -$0.88. Gross margin also dropped significantly to -55.47%, down -244.87% YoY.
Analysts have lowered price targets across the board, with Barclays setting a target of $3 and maintaining an Underweight rating. Roth Capital, B. Riley, and TD Cowen have all reduced their targets while maintaining Buy ratings, but they acknowledge near-term challenges and a tough macro backdrop.
